Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Polyene macrolide; ergosterol inhibitor.
Triazole; 14-α demethylase inhibitor, Smo modu...
COMT inhibitor.
Cyclic peptide; calcineurin inhibitor.
Cationic lipid polypeptide, mixture of polymyxi...
JAK1 inhibitor.
Deubiquitinating enzyme inhibitor.
mTOR activator.
Non-nucleoside RT inhibitor.
Alkaline phosphatase substrate used to quantify...
Polyether Ca2+ ionophore.
Selective Cannabinoid receptor 2(CB2) inverse a...
Aminoquinoline, binds heme, causes cell lysis.<...
Imidazoquinazoline; PDE3 inhibitor.
ACE inhibitor.
Nicotinic acid derivative; InhA inhibitor.
Chalcone; SIRT activator, GABA-A positive modul...
Naturally sourced ITC, sulfonyl analog of sulfo...
Protein translation inhibitor, peptidyl transfe...
Cdc7 inhibitor.